COVID-19 has become one of the worst infectious disease outbreaks of recent times, with
over 2.1 million cases and 120,000 deaths so far. Our study investigated the demographic …

Background: A novel pneumonia (COVID-19) spread rapidly throughout worldwide, in
December, 2019. Most of the deaths have occurred in severe and critical cases, but …

Abstract Coronavirus disease 2019 (COVID‐19) is a respiratory disorder caused by the
highly contagious severe acute respiratory syndrome coronavirus 2. The …

Objectives To explore the clinical course and its dynamic features of immune status in
COVID-19 patients and find predictors correlated with severity and prognosis of COVID-19 …

Objective: To describe the clinical manifestations and outcomes of COVID-19, and explore
the risk factors of deterioration and death of the disease. Methods: In this retrospective study …

Abstract Background In December 2019, coronavirus 2019 (COVID-19) emerged in Wuhan
and rapidly spread throughout China. Methods Demographic and clinical data of all …

The outbreak of coronavirus disease 2019 (COVID-19), caused by the novel coronavirus
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused a threat to …

Recently, the novel coronavirus disease (COVID-19) has broken out worldwide, 1 with rapid
increase of infected patients. COVID-19 dominantly leads to pneumonia. 2 Among these …

Importance An ongoing outbreak of COVID-19 has exhibited significant threats around the
world. We found a significant decrease of T lymphocyte subsets and an increase of …

Background Crucial roles of hematologic and immunologic responses in progression of
coronavirus disease 2019 (COVID-19) remain largely unclear. Objective We sought to …